FDA Inspection
BRI Institutional Review Board, Inc.BRI Institutional Review Board, Inc. – FDA Inspection, Feb 7, 2013
Record Details
This FDA Inspection record concerns BRI Institutional Review Board, Inc., with an inspection on February 7, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- February 7, 2013
- Product Type
- Drugs
View Company Profile
ID · 8dcb503b-4411-4bbb-bb04-18b33705af80
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 817018
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
7- 21 CFR 56.115(a)(5)List of members
- 21 CFR 56.111(a)(2)Risks to subjects reasonable
- 21 CFR 56.109(h)Children as subjects
- 21 CFR 56.108(a)(1)Initial and continuing reviews
- 21 CFR 56.108(b)(2)Prompt reporting of noncompliance
- 21 CFR 56.108(b)(1)Prompt reporting of unanticipated problems
- 21 CFR 56.110(b)Research not eligible for expedited review
Full citation text and observation details available on the Dashboard.
Other FDA inspections of BRI Institutional Review Board, Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| October 28, 2010 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| December 10, 2008 | OAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for BRI Institutional Review Board, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.